Literature DB >> 15564463

Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription.

Meisheng Zhou1, Longwen Deng, Vincent Lacoste, Hyeon Ung Park, Anne Pumfery, Fatah Kashanchi, John N Brady, Ajit Kumar.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) Tat protein recruits positive transcription elongation factor b (P-TEFb) to the transactivation response (TAR) RNA structure to facilitate formation of processive transcription elongation complexes (TECs). Here we examine the role of the Tat/TAR-specified cyclin-dependent kinase 9 (CDK9) kinase activity in regulation of HIV-1 transcription elongation and histone methylation. In HIV-1 TECs, P-TEFb phosphorylates the RNA polymerase II (RNAP II) carboxyl-terminal domain (CTD) and the transcription elongation factors SPT5 and Tat-SF1 in a Tat/TAR-dependent manner. Using in vivo chromatin immunoprecipitation analysis, we demonstrate the following distinct properties of the HIV-1 transcription complexes. First, the RNAP II CTD is phosphorylated at Ser 2 and Ser 5 near the promoter and at downstream coding regions. Second, the stable association of SPT5 with the TECs is dependent upon P-TEFb kinase activity. Third, P-TEFb kinase activity is critical for the induction of methylation of histone H3 at lysine 4 and lysine 36 on HIV-1 genes. Flavopiridol, a potent P-TEFb kinase inhibitor, inhibits CTD phosphorylation, stable SPT5 binding, and histone methylation, suggesting that its potent antiviral activity is due to its ability to inhibit several critical and unique steps in HIV-1 transcription elongation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15564463      PMCID: PMC533906          DOI: 10.1128/JVI.78.24.13522-13533.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  78 in total

Review 1.  Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation.

Authors:  R Taube; K Fujinaga; J Wimmer; M Barboric; B M Peterlin
Journal:  Virology       Date:  1999-11-25       Impact factor: 3.616

2.  Kin28, the TFIIH-associated carboxy-terminal domain kinase, facilitates the recruitment of mRNA processing machinery to RNA polymerase II.

Authors:  C R Rodriguez; E J Cho; M C Keogh; C L Moore; A L Greenleaf; S Buratowski
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

3.  Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo.

Authors:  S H Chao; D H Price
Journal:  J Biol Chem       Date:  2001-06-28       Impact factor: 5.157

4.  PITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo.

Authors:  M O Gold; X Yang; C H Herrmann; A P Rice
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA.

Authors:  P Wei; M E Garber; S M Fang; W H Fischer; K A Jones
Journal:  Cell       Date:  1998-02-20       Impact factor: 41.582

6.  Identification of multiple cyclin subunits of human P-TEFb.

Authors:  J Peng; Y Zhu; J T Milton; D H Price
Journal:  Genes Dev       Date:  1998-03-01       Impact factor: 11.361

7.  Roscovitine, a specific inhibitor of cellular cyclin-dependent kinases, inhibits herpes simplex virus DNA synthesis in the presence of viral early proteins.

Authors:  L M Schang; A Rosenberg; P A Schaffer
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

8.  DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs.

Authors:  T Wada; T Takagi; Y Yamaguchi; A Ferdous; T Imai; S Hirose; S Sugimoto; K Yano; G A Hartzog; F Winston; S Buratowski; H Handa
Journal:  Genes Dev       Date:  1998-02-01       Impact factor: 11.361

9.  Characterization of the residues phosphorylated in vitro by different C-terminal domain kinases.

Authors:  S Trigon; H Serizawa; J W Conaway; R C Conaway; S P Jackson; M Morange
Journal:  J Biol Chem       Date:  1998-03-20       Impact factor: 5.157

10.  Induction of developmentally programmed cell death and activation of HIV by sodium butyrate.

Authors:  M R Sadaie; G L Hager
Journal:  Virology       Date:  1994-07       Impact factor: 3.616

View more
  40 in total

Review 1.  Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transport.

Authors:  Italo Mocchetti; Alessia Bachis; Valeriya Avdoshina
Journal:  Neurotox Res       Date:  2011-09-27       Impact factor: 3.911

2.  Use of ATP analogs to inhibit HIV-1 transcription.

Authors:  Aarthi Narayanan; Gavin Sampey; Rachel Van Duyne; Irene Guendel; Kylene Kehn-Hall; Jessica Roman; Robert Currer; Hervé Galons; Nassima Oumata; Benoît Joseph; Laurent Meijer; Massimo Caputi; Sergei Nekhai; Fatah Kashanchi
Journal:  Virology       Date:  2012-07-06       Impact factor: 3.616

3.  Are viral-encoded microRNAs mediating latent HIV-1 infection?

Authors:  Marc S Weinberg; Kevin V Morris
Journal:  DNA Cell Biol       Date:  2006-04       Impact factor: 3.311

4.  Tip110 protein binds to unphosphorylated RNA polymerase II and promotes its phosphorylation and HIV-1 long terminal repeat transcription.

Authors:  Weina Zhao; Ying Liu; Khalid Amine Timani; Johnny J He
Journal:  J Biol Chem       Date:  2013-11-11       Impact factor: 5.157

5.  HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP.

Authors:  Bijan Sobhian; Nadine Laguette; Ahmad Yatim; Mirai Nakamura; Yves Levy; Rosemary Kiernan; Monsef Benkirane
Journal:  Mol Cell       Date:  2010-05-14       Impact factor: 17.970

6.  Epigenetic silencing of HIV-1 by the histone H3 lysine 27 methyltransferase enhancer of Zeste 2.

Authors:  Julia Friedman; Won-Kyung Cho; Chung K Chu; Kara S Keedy; Nancie M Archin; David M Margolis; Jonathan Karn
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

7.  NF-kappaB-repressing factor inhibits elongation of human immunodeficiency virus type 1 transcription by DRB sensitivity-inducing factor.

Authors:  Ursula Dreikhausen; Kirsten Hiebenthal-Millow; Myriam Bartels; Klaus Resch; Mahtab Nourbakhsh
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

8.  Selective control of gene expression by CDK9 in human cells.

Authors:  Judit Garriga; Hongbo Xie; Zoran Obradovic; Xavier Graña
Journal:  J Cell Physiol       Date:  2010-01       Impact factor: 6.384

9.  microRNA machinery is an integral component of drug-induced transcription inhibition in HIV-1 infection.

Authors:  Lawrence Carpio; Zachary Klase; William Coley; Irene Guendel; Sarah Choi; Rachel Van Duyne; Aarthi Narayanan; Kylene Kehn-Hall; Laurent Meijer; Fatah Kashanchi
Journal:  J RNAi Gene Silencing       Date:  2010-05-29

10.  RNA Genes: Retroelements and Virally Retroposable microRNAs in Human Embryonic Stem Cells.

Authors:  Yoichi R Fujii
Journal:  Open Virol J       Date:  2010-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.